Abstract
Skeletal muscle cells can be used in vitro for the study of myogenests, as well as in VIVO as gene-delivery vehicles for the therapy of muscle and nonmuscle diseases (1–9). These skeletal muscle cells are derived from muscle satellite cells, which he between the basal lamina and the sarcolemma of differentiated muscle fibers (10) Normally quiescent after the period of muscle development and growth during fetal life and the early postnatal period, these cells are induced to proliferate on muscle damage and fuse with existing muscle fibers Satellite cells isolated and grown in vitro are called myoblasts Myoblasts proliferate in mitogen-rich media, but on reaching high cell density followed by exposure to mitogen-poor media, are induced to differentiate and become postmitotic Muscle differentiation is characterized by the fusion of myoblasts to form multinucleated myotubes, which express differentiation-specific proteins. In this chapter, methods are given for the isolation of myoblasts from human muscle tissue using two different techinques flow cytometry (11) and cell cloning (12–14). These methods are applicable to muscle tissue from both fetal and postnatal donors, as well as from normal and diseased individuals
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Barr, E and Leiden, J M (1991) Systemic delivery of recombinant proteins by genetically modified myoblasts. Science 254, 1507–1509
Dhawan, J, Pan, L C, Pavlath, G K, Travis M A, Lanctot A M, and Blau H M (1991) Systemic delivery of human growth hormone by injection of genetically engmeered myoblasts Science 254, 1509–1512
Dal, Y, Roman, M, Naviaux, R K, and Verma, I M (1992) Gene therapy via primary myoblasts long-term expression of factor IX protein following transplantation in vivo Proc Natl Acad Sci USA 89, 10,892–10,895
Gussom E, Pavlath, G. K, Lanctot, A M, Sharma, K R, Miller, R G, Steinman, L, and Blau, H M (1992) Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation Nature 356, 435–438
Jiao, S, Gurevich, V, and Wolff, J A, (1993) Long-term correction of rat model of Parkinson’s disease by gene therapy Nature 362, 450–453
Karpati, G, Ajdukovic, D, Arnold, D, Gledhill, R B, Guttmann, R, Holland, P, Koch, P. A, Shoubndge E, Spence D, Vanasse M, Watters G. V, Abrahamowicz M, Duff C, and Worton R (1993) Myoblast transfer in Duchenne muscular dystrophy Ann Neurol 34, 8–17
Law, P K, Goodwin, T G, Fang, Q, Duggirala, V, Larkin, C, Florendo, J A, Kirby, D S, Deering, M B, Li, H J, Chen, M, Cormett, J, Li, L M, Shirzad, A, Quinley, T, Yoo, T J, and Holcome, R (1992) Feasibility, safety, and efficacy of myoblast transfer therapy on Duchenne muscular dystrophy boys Cell Transplant 1, 235–244
Tremblay, J P, Maloum, F, Roy, R, Huard, J, Bouchard, J P, Satoh, A, and Richards, C L. (1993) Results of a triple blind cluucal study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy Cell Transplant 2, 99–112
Yao, S-N, Smith, K J, and Kurachi, K (1994) Primary myoblast-mediated gene transfer persistent expression of human factor IX in mice Gene nerapy 1, 99–107
Mauro, A. (1961) Satellite cells of skeletal muscle fibers J Biophys Biochem cytol 9, 493–495
Webster, C., Pavlath, G K, Parks, D. R, Walsh, F S, and Blau, H M (1988) Isolation of human myoblasts with the fluorescence-activated cell sorter. Exp Cell Res 174, 252–265
Blau, H M. and Webster, C (1981) Isolation and characterization of human muscle cells Proc Natl Acad Sci USA 78, 5623–5627
Blau, H. M, Webster, C., and Pavlath, G K. (1983) Defective myoblasts identified in Duchenne muscular dystrophy Proc Natl Acad Sci USA 80, 4856–4860
Webster, C and Blau, H. in. (1990) Accelerated age-related decline in replicative life-span of Duchenne inuscular dystrophy inyoblasts: iinplications for cell and gene therapy Soinat Cell inol Genet 16, 557–565
Walsh, F W and Ritter, M A (1981) Surface antigen differentiation during inyogenesis in culture Nature 289, 60–64.
Hain, R. G, St Clair, J A, Webster, C., and Blau, H M (1988) Improved media for normal human muscle satellite cells. serum-free clonal growth and enhanced growth with low serum In Vitro Cell Dev. Biol 24, 833–844
Lanier, L L, Testi, R, Binal, J, and Phillips, J. H (1989) Identity of Leu-19 (CD56) Leukocyte differentiation antigen and neural cell adhesion molecule J Exp Med 169, 2233–2238
Schubert, W, Zimmerman, K, Cramer, M, and Starzinski-Powitz, A (1989) Lymphocyte antigen Leu-19 as a marker of regeneration in human skeletal muscle. Proc Natl Acad Sci USA 86, 307–311
Illa, I, Leon-Monzon, M, and Dalakas, M C (1992) Regenerating and denervated human muscle fibers and satellite cells express neural cell adhesion inol ecule recognized by monoclonal antibodies to natural killer cells. Ann Neurol 31, 46–52
Michaelis, D, Goebels, N., and Hohlfeld, R. (1993) Constitutive and cytokineinduced expression of human leukocyte antigens and cell adhesion molecules by human myotubes. Am J Pathol 143, 1142–1149.
Hohlfeld, R. and Engel, A G (1990) Induction of HLA-DR expression on human myoblasts with interferon-gamma Am J Pathol 136, 503–508
Hohlfeld, R and Engel, A G (1990) Lysts of myotubes by alloreactive cytotoxic T cells and natural killer cells Relevance to myoblast transplantation J Clin Invest 86, 370–374
St Clair, J. A, Meyer-Demarest, S. D., and Ham, R G (1992) Improved media with EGF and BSA for differentiated human skeletal muscle cells Muscle and Nerve 15, 774–779
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Pavlath, G.K. (1996). Isolation, Purification, and Growth of Human Skeletal Muscle Cells. In: Jones, G.E. (eds) Human Cell Culture Protocols. Methods in Molecular Medicine, vol 2. Humana Press. https://doi.org/10.1385/0-89603-335-X:307
Download citation
DOI: https://doi.org/10.1385/0-89603-335-X:307
Publisher Name: Humana Press
Print ISBN: 978-0-89603-335-1
Online ISBN: 978-1-59259-586-0
eBook Packages: Springer Protocols